Edithistory:Cerebroprotectants
From EverybodyWiki Bios & Wiki
| oldid | date/time | username | edit summary |
|---|---|---|---|
| 1119420239 | 2022-11-01T13:56:53Z | GroppeBoucher | |
| 1105573316 | 2022-08-20T21:17:16Z | Citation bot | Add: pmid, bibcode, s2cid. Removed proxy/dead URL that duplicated identifier. Removed parameters. | [[WP:UCB|Use this bot]]. [[WP:DBUG|Report bugs]]. | Suggested by Headbomb | [[Category:CS1 maint: PMC embargo expired]] | #UCB_Category 6/43 |
| 1105090618 | 2022-08-18T13:24:57Z | JCW-CleanerBot | /* List of cerebroprotectants tested in clinical trials */[[User:JCW-CleanerBot#Logic|task]], replaced: Brain : A Journal of Neurology → Brain: A Journal of Neurology |
| 1096535959 | 2022-07-05T02:52:04Z | Smasongarrison | /* List of cerebroprotectants tested in clinical trials */[[WP:AWB/GF|General]] fixes + punctuation fixed per [[MOS:CONFORM]] etc, replaced: ′ → ' |
| 1093982664 | 2022-06-20T01:58:23Z | JCW-CleanerBot | /* List of cerebroprotectants tested in clinical trials */[[User:JCW-CleanerBot#Logic|task]], replaced: American Journal of Physiology- → American Journal of Physiology. |
| 1093937946 | 2022-06-19T19:53:07Z | JCW-CleanerBot | /* List of cerebroprotectants tested in clinical trials */[[User:JCW-CleanerBot#Logic|task]], removed: : JVIR |
| 1093937856 | 2022-06-19T19:52:22Z | JCW-CleanerBot | /* List of cerebroprotectants tested in clinical trials */[[User:JCW-CleanerBot#Logic|task]], replaced: Science (New York, N.Y.) → Science (2), Lancet (London, England) → Lancet |
| 1092323748 | 2022-06-09T15:56:55Z | Citation bot | Alter: pages, doi, issue, journal. Add: hdl, doi-access, page, s2cid, doi, pages, issue, volume, pmc-embargo-date, pmc, pmid, authors 1-1. Removed proxy/dead URL that duplicated identifier. Removed parameters. Formatted [[WP:ENDASH|dashes]]. Some additions/deletions were parameter name changes. | [[WP:UCB|Use this bot]]. [[WP:DBUG|Report bugs]]. | Suggested by Headbomb | Linked from Wikipedia:WikiProject_Academic_Journals/Journals_cited_by_Wikipedia/Sandbox | #UCB_webform_linked 229/235 |
| 1091948740 | 2022-06-07T10:21:26Z | Keith D | /* List of cerebroprotectants tested in clinical trials */Fix cite date error |
| 1091614149 | 2022-06-05T09:48:12Z | Oculi | clean up, replaced: =PMC → = (5), [[WP:AWB/T|typo(s) fixed]]: from 2011-2022 → from 2011 to 2022, $1.3 billion USD → US$1.3 billion, demostrated → demonstrated, Opiod → Opioid (2), treatement → treatment, aquired → acquired, artifica |
| 1091486481 | 2022-06-04T16:15:20Z | AnomieBOT | [[User:AnomieBOT/docs/TemplateSubster|Substing templates]]: {{Twocopies}}. See [[User:AnomieBOT/docs/TemplateSubster]] for info. |
| 1091483919 | 2022-06-04T15:59:01Z | Robert McClenon | Declining submission: exists - Submission is duplicated by another article already in mainspace ([[WP:AFCH|AFCH]] 0.9.1) |
| 1091402613 | 2022-06-04T02:26:48Z | Eagleash | fix hdgs to level 2 (rm from AfC 'no sections' cat) reflist |
| 1091391521 | 2022-06-04T00:45:03Z | RichBot | ([[WP:BOT|Beep, Boop]]). I have removed a template which is not valid in Draftspace |
| 1091391431 | 2022-06-04T00:44:19Z | Robert McClenon | Robert McClenon moved page [[User:LearningFromJournals/sandbox]] to [[Draft:Cerebroprotectants]]: Preferred location for [[WP:AFC|AfC]] submissions |
| 1091375029 | 2022-06-03T22:08:51Z | LearningFromJournals | Submitting using [[WP:AFCSW|AfC-submit-wizard]] |
| 1091374670 | 2022-06-03T22:06:09Z | LearningFromJournals | /* Methods to Increase the Approval Rate */ |
| 1091373113 | 2022-06-03T21:55:34Z | LearningFromJournals | |
| 1091372637 | 2022-06-03T21:52:51Z | LearningFromJournals | |
| 1091368934 | 2022-06-03T21:31:15Z | LearningFromJournals | Adding references |
| 1091364364 | 2022-06-03T21:08:57Z | LearningFromJournals | Adding references |
| 1091358274 | 2022-06-03T20:20:39Z | LearningFromJournals | Added references |
| 1091353668 | 2022-06-03T19:41:20Z | LearningFromJournals | Added references |
| 1091350474 | 2022-06-03T19:16:16Z | LearningFromJournals | Cleaning up references |
| 1091349831 | 2022-06-03T19:10:54Z | LearningFromJournals | /* Approval rate for drugs in development */ |
| 1091104879 | 2022-06-02T06:51:49Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1091104861 | 2022-06-02T06:51:34Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1091104560 | 2022-06-02T06:47:56Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1091104267 | 2022-06-02T06:44:57Z | LearningFromJournals | /* Methods to Increase the Approval Rate */ |
| 1091103922 | 2022-06-02T06:40:59Z | LearningFromJournals | Cleaning up references |
| 1091102387 | 2022-06-02T06:23:23Z | LearningFromJournals | /* Approved Cerebroprotectants */ |
| 1091102309 | 2022-06-02T06:22:44Z | LearningFromJournals | |
| 1091102055 | 2022-06-02T06:20:51Z | LearningFromJournals | Cleaning up references |
| 1091100930 | 2022-06-02T06:09:54Z | LearningFromJournals | Cleaning up references |
| 1090897774 | 2022-06-01T01:17:23Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1090897535 | 2022-06-01T01:16:05Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1090893055 | 2022-06-01T00:44:25Z | LearningFromJournals | |
| 1090892564 | 2022-06-01T00:40:54Z | LearningFromJournals | |
| 1090892365 | 2022-06-01T00:39:17Z | LearningFromJournals | |
| 1090823469 | 2022-05-31T15:45:22Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1090818767 | 2022-05-31T15:09:40Z | LearningFromJournals | /* Methods to Improve the Approval Rate */ |
| 1090818486 | 2022-05-31T15:07:13Z | LearningFromJournals | /* Methods to Improve the Approval Rate */ |
| 1090818287 | 2022-05-31T15:05:44Z | LearningFromJournals | |
| 1090697508 | 2022-05-30T21:48:32Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090697171 | 2022-05-30T21:46:01Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090697000 | 2022-05-30T21:44:52Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090696402 | 2022-05-30T21:40:47Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090695960 | 2022-05-30T21:37:29Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090695659 | 2022-05-30T21:35:24Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090693614 | 2022-05-30T21:21:22Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090687954 | 2022-05-30T20:45:45Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090687880 | 2022-05-30T20:45:19Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090687771 | 2022-05-30T20:44:44Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090687559 | 2022-05-30T20:43:23Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090687045 | 2022-05-30T20:40:20Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090686646 | 2022-05-30T20:37:51Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090686465 | 2022-05-30T20:36:49Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090686250 | 2022-05-30T20:35:35Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090685961 | 2022-05-30T20:33:47Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090684989 | 2022-05-30T20:28:21Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090683358 | 2022-05-30T20:19:59Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090683241 | 2022-05-30T20:19:08Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1090680422 | 2022-05-30T20:00:27Z | LearningFromJournals | |
| 1089492923 | 2022-05-24T03:47:46Z | LearningFromJournals | |
| 1089492550 | 2022-05-24T03:43:19Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089492432 | 2022-05-24T03:41:59Z | LearningFromJournals | /* Approved Cerebroprotectants */ |
| 1089492371 | 2022-05-24T03:41:13Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089491784 | 2022-05-24T03:34:26Z | LearningFromJournals | |
| 1089491694 | 2022-05-24T03:33:28Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089491548 | 2022-05-24T03:31:55Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489826 | 2022-05-24T03:14:00Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489466 | 2022-05-24T03:10:36Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489424 | 2022-05-24T03:10:05Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489391 | 2022-05-24T03:09:38Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489332 | 2022-05-24T03:09:03Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489265 | 2022-05-24T03:08:23Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489173 | 2022-05-24T03:07:34Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489135 | 2022-05-24T03:07:10Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089489001 | 2022-05-24T03:05:35Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089488956 | 2022-05-24T03:05:05Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089488372 | 2022-05-24T02:59:08Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089487970 | 2022-05-24T02:54:45Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089487155 | 2022-05-24T02:45:38Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089487038 | 2022-05-24T02:44:30Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089484810 | 2022-05-24T02:23:33Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089482666 | 2022-05-24T02:02:55Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089481880 | 2022-05-24T01:57:17Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1089481806 | 2022-05-24T01:56:37Z | LearningFromJournals | /* Approved Cerebroprotectants */ |
| 1089481686 | 2022-05-24T01:55:34Z | LearningFromJournals | /* Approved Cerebroprotectants */ |
| 1087385558 | 2022-05-12T03:45:58Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1087381220 | 2022-05-12T02:57:55Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1087381179 | 2022-05-12T02:57:17Z | LearningFromJournals | |
| 1087381127 | 2022-05-12T02:56:38Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1087379232 | 2022-05-12T02:39:07Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1087379113 | 2022-05-12T02:37:56Z | LearningFromJournals | /* List of cerebroprotectants tested in clinical trials */ |
| 1087324924 | 2022-05-11T19:42:01Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1087324660 | 2022-05-11T19:40:09Z | LearningFromJournals | /* Approved Cerebroprotectants */ |
| 1087324418 | 2022-05-11T19:38:26Z | LearningFromJournals | |
| 1087324266 | 2022-05-11T19:37:19Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1087323593 | 2022-05-11T19:31:57Z | LearningFromJournals | /* Approved Cerebroprotectants */ |
| 1087323238 | 2022-05-11T19:29:12Z | LearningFromJournals | /* Approved Cerebroprotectants */ |
| 1087322571 | 2022-05-11T19:23:38Z | LearningFromJournals | /* Approved Cerebroprotectants */ |
| 1087322371 | 2022-05-11T19:21:58Z | LearningFromJournals | /* Success rate for drugs in development */ |
| 1087320326 | 2022-05-11T19:05:03Z | LearningFromJournals | /* Success rate for drugs */ |
| 1087289668 | 2022-05-11T15:25:31Z | LearningFromJournals | |
| 1087285414 | 2022-05-11T14:57:03Z | LearningFromJournals | |
| 1087285109 | 2022-05-11T14:54:24Z | LearningFromJournals | |
| 1087284980 | 2022-05-11T14:53:22Z | LearningFromJournals | |
| 1087283549 | 2022-05-11T14:42:36Z | LearningFromJournals | |
| 1087142328 | 2022-05-10T16:41:00Z | LearningFromJournals | |
| 1067908806 | 2022-01-25T19:34:08Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067908646 | 2022-01-25T19:33:10Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067904720 | 2022-01-25T19:07:20Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067904616 | 2022-01-25T19:06:39Z | LearningFromJournals | |
| 1067904056 | 2022-01-25T19:02:40Z | LearningFromJournals | |
| 1067903887 | 2022-01-25T19:01:39Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067903209 | 2022-01-25T18:57:09Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067903076 | 2022-01-25T18:56:03Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067903003 | 2022-01-25T18:55:30Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067901426 | 2022-01-25T18:45:18Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067900657 | 2022-01-25T18:40:49Z | LearningFromJournals | /* Noteable Perfluorocarbon Emulsions */ |
| 1067899643 | 2022-01-25T18:34:17Z | LearningFromJournals | |
| 1067899300 | 2022-01-25T18:32:05Z | LearningFromJournals | |
| 1067899022 | 2022-01-25T18:30:14Z | LearningFromJournals | |
| 1067898823 | 2022-01-25T18:28:56Z | LearningFromJournals | |
| 1067892795 | 2022-01-25T17:51:35Z | LearningFromJournals | |
| 1067890684 | 2022-01-25T17:38:27Z | LearningFromJournals | |
| 1067886516 | 2022-01-25T17:13:53Z | LearningFromJournals | |
| 1067880538 | 2022-01-25T16:37:18Z | LearningFromJournals | |
| 1067875737 | 2022-01-25T16:10:24Z | LearningFromJournals | |
| 1062878794 | 2021-12-31T00:43:54Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062878618 | 2021-12-31T00:42:50Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062878330 | 2021-12-31T00:41:07Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062877875 | 2021-12-31T00:38:07Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062875972 | 2021-12-31T00:28:09Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062875747 | 2021-12-31T00:26:57Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062873909 | 2021-12-31T00:18:21Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062873650 | 2021-12-31T00:16:40Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062848748 | 2021-12-30T22:20:34Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062808534 | 2021-12-30T17:28:10Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062808285 | 2021-12-30T17:26:04Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062806327 | 2021-12-30T17:10:56Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062805604 | 2021-12-30T17:05:43Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062804445 | 2021-12-30T16:57:29Z | LearningFromJournals | /* Oxygen Therapeutics */ |
| 1062803847 | 2021-12-30T16:53:02Z | LearningFromJournals | [[WP:AES|←]]Created page with '{{User sandbox}} <!-- EDIT BELOW THIS LINE --> Perfluorocarbon emulsions are [[emulsions]] containing either bubbles or droplets which have [[perfluorocarbons]] inside them. Some of them are commonly used in medicine as ultrasound contrast agents, and others have been studied for use as oxygen therapeutics. === Ultrasound Contrast Agents === The most common use of perfluorocarbon emulsions is as ultrasound contrast agents. In this application, microscopi...' |
